超加工食品消费和刺激性肠综合征:当前证据和临床影响
Hanna Fjeldheim Dale1, Marit Kolby2, Jørgen Valeur1,3
1Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, 0456 Oslo, Norway.
Nutrients
|November 27, 2025
概括
超加工食品的消费可能会增加易怒肠综合征 (IBS) 的风险,易怒肠综合征是一种肠脑相互作用障碍. 减少超加工食品可能有助于通过改善肠道健康来管理IBS症状.
科学领域:
- 胃肠病学和营养科学 胃肠病学和营养科学
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的肠脑相互作用障碍,影响生活质量.
- 全球超加工食品 (UPF) 的消费量正在上升,与慢性疾病有关.
研究的目的:
- 审查UPF消费与IBS之间的关联的证据.
- 探索机械学的见解和临床影响.
主要方法:
- 叙述性综述综合流行病学,实验和临床研究.
- 对UPF摄入量和IBS风险的观察数据的分析.
- 检查涉及食品添加剂的机械路径.
主要成果:
- 观察性研究表明,更高的UPF摄入量与IBS风险增加有关,尽管证据有限.
- 机械学研究表明,UPF添加剂可以改变肠道微生物群,损害肠道屏障,促进炎症.
- 目前的证据表明,UPF和IBS之间存在潜在的联系.
结论:
- 减少UPF摄入量和改善饮食质量是IBS管理的潜在补充策略.
- 需要进一步的干预试验来证实这种联系,并探索潜在的生物机制.
相关概念视频
Irritable Bowel Syndrome I: Introduction
893
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
893
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
710
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
710
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
617
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617
Irritable Bowel Syndrome III: Medical and Nursing Management
617
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
617
Chronic Bowel Disorders: Introduction
734
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
734
Drugs for Treatment of Constipation-Predominant IBS
680
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
680


